Unlock AI-driven, actionable R&D insights for your next breakthrough.

High Molecular Weight Chitosan: Advanced Production Methods, Structural Properties, And Multifunctional Applications In Biomedical And Industrial Fields

APR 14, 202666 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
High molecular weight chitosan (HMW chitosan), typically defined as chitosan with molecular weight exceeding 300 kDa and often ranging from 500 kDa to over 2000 kDa, represents a critical biopolymer derived from chitin deacetylation with exceptional biocompatibility, biodegradability, and cationic properties 48. The molecular weight profoundly influences mechanical strength, viscosity, mucoadhesion, and biological activity, making HMW chitosan particularly valuable in tissue engineering scaffolds, drug delivery systems, wound healing applications, and antimicrobial formulations 58. Despite its superior performance characteristics compared to low molecular weight variants, HMW chitosan presents significant challenges in solubilization, chemical modification, and processing due to extensive inter- and intramolecular hydrogen bonding networks 613.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Structure And Physicochemical Characteristics Of High Molecular Weight Chitosan

High molecular weight chitosan is a linear polysaccharide composed of β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine units, distinguished by its degree of deacetylation (DD) typically exceeding 70% and molecular weight (Mw) ranging from 350 kDa to over 2000 kDa 58. The molecular architecture directly determines critical physicochemical properties including solution viscosity, mechanical strength, and biological interactions 15. One fundamental classification differentiates low-molecular (Mw ~150,000 Da), medium-molecular (Mw ~400,000 Da), and high-molecular (Mw ~600,000 Da or higher) chitosan types, with HMW variants exhibiting superior film-forming capacity and structural integrity 15.

The cationic nature of chitosan under physiological conditions, arising from protonation of amino groups at C-2 positions (pKa ~6.5), enables electrostatic interactions with anionic biomolecules including proteins, DNA, fatty acids, and phospholipids 15. This positive charge density increases proportionally with the degree of deacetylation, directly impacting antimicrobial efficacy and mucoadhesive properties 717. For pharmaceutical and biomedical applications, HMW chitosan with Mw between 500-1200 kDa and DD of 90-95% demonstrates optimal balance between mechanical performance and biological activity 57.

Intrinsic Viscosity And Rheological Behavior

The intrinsic viscosity of HMW chitosan solutions serves as a critical parameter for molecular weight determination and processability assessment. High-quality water-soluble chitosan oligosaccharides exhibit intrinsic viscosity ranging from 0.020 to 0.250 dL/g, with higher molecular weight fractions displaying proportionally elevated values 7. In alkaline solvent systems designed for HMW chitosan dissolution (molecular weight 1-6 million Da), the viscosity-temperature relationship becomes crucial for processing window optimization, requiring precise control of composition including 1.0-5.0 wt% lithium hydroxide, 0-4.0 wt% sodium hydroxide, 4.0-9.0 wt% urea, and 0.1-3.0 wt% glycerin in aqueous medium 6.

The strong intermolecular hydrogen bonding characteristic of HMW chitosan results in poor solubility in water and most organic solvents at neutral pH, necessitating acidic conditions (typically acetic acid solutions) or specialized alkaline solvent systems for dissolution 617. This solubility challenge represents a primary obstacle for industrial applications, as residual acids from conventional dissolution methods can cause skin irritation in biomedical formulations 17.

Degree Of Deacetylation And Its Impact On Functionality

The degree of deacetylation fundamentally governs the density of free amino groups available for protonation and subsequent biological interactions. High-quality HMW chitosan for biomedical applications typically exhibits DD values of 90-95%, ensuring sufficient cationic charge for antimicrobial activity while maintaining structural integrity 7. The deacetylation process involves repeated treatment of chitin with hot concentrated alkali (35-50% NaOH, 1-3 hours, 90-130°C), with careful control required to prevent excessive chain scission that would reduce molecular weight 1115.

Advanced production methods employ freeze-thaw cycles (at least six cycles) prior to boiling in concentrated soda solution at temperatures ≤100°C under reduced pressure and oxygen-free conditions, enabling achievement of near-complete deacetylation while preserving high molecular weight 11. Each freeze-thaw cycle comprises: (a) submersion in cooling medium until complete freezing, (b) degassing to sub-atmospheric pressure, and (c) gradual heating until complete thawing 11. This methodology addresses the traditional trade-off between achieving high DD and maintaining elevated Mw.

Advanced Production Technologies For High Molecular Weight Chitosan

Mechanochemical Synthesis Routes

Recent innovations in mechanochemical processing have revolutionized HMW chitosan production by enabling solid-state deacetylation with reduced energy consumption and environmental impact compared to conventional solution-phase methods 23. The mechanochemical approach involves milling or grinding chitin with deacetylation reagents (typically NaOH) in specialized equipment including mixer mills, planetary mills, or vibrating ball mills, followed by controlled aging to complete the deacetylation reaction 23.

A critical advancement involves the combination of liquid-assisted grinding (LAG) with humidity-controlled aging (98% relative humidity, 22°C) for approximately 6 days, which produces chitosan with DD <30% initially but can be increased through extended aging 3. However, this method proves time-consuming and economically challenging for industrial scale-up 3. Alternative high-pressure processes can generate HMW chitosan (>1000 kDa) with superior mechanical properties but present safety concerns and energy intensity limitations 3.

The most promising mechanochemical route employs vibrating ball mill processing under controlled atmosphere (nitrogen environment) with subsequent aging, enabling production of chitosan with molecular weight exceeding 500 kDa while maintaining DD >85% 2. The process parameters include:

  • Milling conditions: Ball-to-powder ratio 10:1 to 20:1, milling frequency 25-35 Hz, duration 30-120 minutes
  • Reagent composition: NaOH to chitin mass ratio 1.5:1 to 3:1, with optional addition of water (5-15 wt%) for LAG
  • Aging protocol: Temperature 20-25°C, relative humidity 95-98%, duration 3-7 days under nitrogen atmosphere
  • Yield and purity: Typical yields 75-85% with residual acetyl content <10% 23

Squid Pen-Derived High Molecular Weight Chitosan Production

Squid pens (gladius) represent an underutilized marine waste stream from fishing industry operations, offering a sustainable and economically attractive chitin source for HMW chitosan production 5. The optimized extraction protocol involves:

  1. Particle size preparation: Milling squid pen and sieving to select particles with size 63-125 μm, which provides optimal surface area for deacetylation while minimizing mechanical degradation 5
  2. Deacetylation reaction: Reacting NaOH with selected particles for ≥1.5 hours (optimally 2 hours) at 75°C under continuous stirring in nitrogen atmosphere to prevent oxidative degradation 5
  3. Washing and neutralization: Employing water-efficient washing protocols to reduce environmental impact, a significant improvement over conventional methods requiring 5-3.5 hours of washing 5
  4. Product characteristics: Resulting HMW chitosan exhibits Mw between 350-1500 kDa (preferably 500-1200 kDa, most preferably 800-1100 kDa) with DD >88% and concentration capability up to 0.1 mg/mL in acidic solutions 5

This squid pen-derived chitosan demonstrates excellent biocompatibility for tissue engineering applications including bone, cartilage, osteochondral, joint, muscle, musculoskeletal, ligament, tendon, connective tissue, ocular, skin, vascular, lymphatic, liver, kidney, spleen, pancreas, reproductive organs, peripheral nerve, spinal cord, and brain tissue scaffolds 5.

Enzymatic Molecular Weight Control And Fractionation

While most HMW chitosan production focuses on preserving high molecular weight during deacetylation, controlled enzymatic degradation using chitosanases isolated from Aspergillus oryzae, Aspergillus japonicus, and Aspergillus sojae enables precise molecular weight reduction when lower Mw fractions are required 9. This enzymatic approach offers advantages over chemical or physical degradation methods by:

  • Maintaining consistent molecular weight distribution with polydispersity index (PDI) 1.0-1.5 7
  • Preserving antibacterial activity and solubility characteristics 9
  • Enabling production of specific molecular weight fractions (10,000-500,000 Da) through controlled hydrolysis time and enzyme concentration 9
  • Avoiding structural modifications that alter natural chitosan properties 9

For applications requiring water-soluble HMW chitosan, ultrafiltration membrane fractionation following enzymatic or chemical treatment produces high-purity fractions with narrow molecular weight distribution (average Mw 1,000-11,000 Da, PDI 1.0-1.5, intrinsic viscosity 0.020-0.250 dL/g, DD 90-95%, moisture content 1.0-3.0%, inorganic content 0-1%) 7. These precisely controlled fractions exhibit minimal cytotoxicity and find applications in pharmaceutical formulations and functional health foods 7.

Solubilization Strategies For High Molecular Weight Chitosan

Novel Water-Soluble Formulations Without Mineral Acids

The poor water solubility of HMW chitosan at neutral pH represents a fundamental limitation for many applications, traditionally addressed through dissolution in acetic acid or other mineral acids 48. However, a breakthrough methodology enables production of water-soluble HMW chitosan powder (Mw 70 kDa to 2000 kDa) without requiring mineral acids, surfactants, or plasticizers 48. This approach involves:

  1. Amino acid-mediated dissolution: Dissolving HMW chitosan in warm (40-60°C), odorless aqueous solutions of aspartic acid, glutamic acid, or mixtures thereof at concentrations of 2-8 wt% 48
  2. Salt formation: The amino acids form ionic complexes with chitosan amino groups, disrupting hydrogen bonding networks while maintaining polymer chain integrity 48
  3. Drying and powder production: Spray drying or freeze-drying the solution produces solid-state chitosan-amino acid salt powders that rapidly dissolve in neutral pH water (initial pH 7) 48
  4. Concentration capability: This method enables aqueous chitosan concentrations up to 5-8 wt%, significantly higher than achievable with conventional acetic acid dissolution (typically <2 wt%) 48

The resulting water-soluble HMW chitosan powders maintain biological activities including antimicrobial efficacy against Salmonella enteritidis and other pathogens, making them suitable for food preservation, post-harvest treatments, cosmetic formulations, pharmaceutical products, and medical treatments 48. The powders can be stored in air-tight, light-excluding containers until use, offering convenient commercial handling 8.

Alkaline Solvent Systems For Ultra-High Molecular Weight Chitosan

For chitosan with molecular weight ranging from 1 million to 6 million Da, specialized alkaline solvent systems provide an alternative to acidic dissolution while avoiding the molecular weight degradation inherent in acid-mediated processes 6. The optimized alkaline solvent composition comprises (by weight):

  • Lithium hydroxide: 1.0-5.0%
  • Sodium hydroxide: 0-4.0%
  • Urea: 4.0-9.0%
  • Glycerin: 0.1-3.0%
  • Water: balance 6

This solvent system operates through multiple mechanisms: (a) hydroxide ions disrupt hydrogen bonding, (b) urea acts as a chaotropic agent interfering with water structure, (c) lithium ions provide specific coordination with chitosan hydroxyl groups, and (d) glycerin serves as a co-solvent and viscosity modifier 6. The resulting solutions enable processing of ultra-high-strength chitosan gels, fibers, rod materials, and scaffold structures for tissue engineering applications 6.

Critical processing parameters include:

  • Dissolution temperature: 4-25°C (lower temperatures minimize degradation)
  • Dissolution time: 12-48 hours with gentle stirring
  • Chitosan concentration: 0.5-3.0 wt% depending on molecular weight
  • Stability: Solutions remain stable for 7-14 days at 4°C under nitrogen atmosphere 6

Chemical Modification For Enhanced Solubility

Glycol chitosan, prepared by introducing hydrophilic ethylene glycol groups onto the chitosan backbone, represents a water-soluble derivative exhibiting solubility at neutral pH while maintaining biocompatibility, antibiosis, biodegradability, non-toxicity, and non-immunogenicity 17. The glycol modification disrupts crystallinity and hydrogen bonding without significantly compromising the cationic character responsible for biological activity 17. Typical glycol chitosan exhibits:

  • Molecular weight: 50,000-250,000 Da (lower than parent HMW chitosan due to modification conditions)
  • Degree of substitution: 0.3-0.8 (ethylene glycol groups per glucosamine unit)
  • Solubility: Complete dissolution in water at pH 4-9
  • Viscosity: 10-500 cP at 1 wt% aqueous solution (25°C) 17

For biomedical applications requiring photocrosslinkable hydrogels, visible light-curable water-soluble chitosan derivatives incorporating methacrylate or acrylate groups enable in situ gelation for wound dressing formulations, providing stable wet environment and exudate absorption while maintaining chitosan's therapeutic efficacy 17.

Applications Of High Molecular Weight Chitosan In Biomedical Engineering

Tissue Engineering Scaffolds And Regenerative Medicine

HMW chitosan serves as a premier biomaterial for three-dimensional scaffold fabrication in tissue engineering due to its structural similarity to glycosaminoglycans in native extracellular matrix, excellent biocompatibility, and controllable biodegradation kinetics 15. The molecular weight directly influences scaffold mechanical properties, with HMW chitosan (800-1100 kDa) providing optimal balance between initial strength and degradation rate for bone and cartilage regeneration 5.

3D Printing Technology For Chitosan Scaffolds: Selective laser sintering (SLS) represents an advanced manufacturing approach for producing anatomically precise HMW chitosan scaffolds with controlled porosity and mechanical properties 1. The process involves:

  • Powder preparation: HMW chitosan (Mw 500-1500 kDa) blended with thermal stabilizers (0.1-0.5 parts per 20-25 parts chitosan) to prevent degradation during sintering 1
  • Acid degradation control: Pre-treatment with acid degradation solution (70-80 parts) enables molecular weight adjustment to optimize sintering behavior while maintaining sufficient Mw for mechanical strength 1
  • SLS parameters: Laser power 5-15 W, scan speed 50-200 mm/s, layer thickness 50-150 μm, producing scaffolds with porosity 60-85% and pore size distribution 50-500 μm 1
  • Mechanical properties: Compressive strength 0.5-5 MPa, elastic modulus 10-100 MPa, suitable for non-load-bearing bone tissue applications 1

The resulting scaffolds exhibit shape controllability matching patient-specific wound geometry, particularly valuable for skin tissue engineering where scaffold conformation to irregular wound surfaces enhances healing outcomes 1. The porous structure facilitates cell infiltration, nutrient transport, and vascularization while providing temporary mechanical support during tissue regeneration 1.

Hydrogel Formulations For Soft Tissue Engineering: HMW chitosan hydrogels prepared through physical or chemical crosslinking methods serve as injectable or implantable matrices for soft tissue repair including cartilage, vascular grafts, and neural tissue 5. The hydrogel formation mechanisms include:

  • Physical crosslinking: Ionic interactions with polyanions (alginate, hyaluronic acid) or thermal gelation through hydrophobic associations
  • Chemical crosslinking: C
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
Board of Supervisors of Louisiana State University and Agricultural and Mechanical CollegeFood preservation, post-harvest treatments, cosmetic formulations, pharmaceutical products, and antimicrobial applications against Salmonella enteritidis and other pathogens.Water-Soluble HMW Chitosan PowderAchieves complete water solubility of high molecular weight chitosan (70-2000 kDa) without mineral acids or surfactants using amino acid-mediated dissolution, enabling concentrations up to 5-8 wt% in neutral pH water.
ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING CELL BASED TECHNOLOGIES & THERAPIES (A4TEC)Tissue engineering scaffolds for bone, cartilage, osteochondral, skin, vascular, neural tissues, and regenerative medicine applications requiring biocompatible biomaterials.Squid Pen-Derived HMW ChitosanProduces high molecular weight chitosan (500-1200 kDa, preferably 800-1100 kDa) with degree of deacetylation >88% from sustainable squid pen waste, reducing water consumption in washing and neutralization processes.
ZHEJIANG UNIVERSITYProcessing of high-strength chitosan gels, fibers, rod materials, and scaffold structures for tissue engineering requiring ultra-high mechanical properties.Alkaline Solvent System for Ultra-HMW ChitosanEnables dissolution of ultra-high molecular weight chitosan (1-6 million Da) using alkaline solvent containing lithium hydroxide, sodium hydroxide, urea, and glycerin, avoiding molecular weight degradation from acidic solvents.
THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITYIndustrial-scale production of high-quality chitosan for biomedical applications, drug delivery systems, and antimicrobial formulations requiring controlled molecular weight and purity.Mechanochemical HMW Chitosan ProductionProduces high molecular weight chitosan (>500 kDa) with degree of deacetylation >85% through vibrating ball mill processing under nitrogen atmosphere with controlled aging, reducing energy consumption compared to conventional methods.
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMY COOPERATIONWound dressing formulations requiring stable wet environment and exudate absorption, tissue engineering scaffolds, and biomedical applications requiring neutral pH solubility.Visible Light-Curable Glycol Chitosan HydrogelProvides water-soluble chitosan derivative with biocompatibility, antibiosis, biodegradability, non-toxicity, and non-immunogenicity, enabling photocrosslinkable hydrogel formation for in situ gelation at neutral pH.
Reference
  • A high molecular weight chitosan material with controllable molecular weight suitable for 3D printing and its molding method
    PatentActiveCN103980553B
    View detail
  • Methods for producing chitosan
    PatentActiveUS11597780B2
    View detail
  • Production process for high average molecular weight chitosan biopolymers
    PatentWO2024072249A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png